Global use of ADHD medications rose threefold from 1993 through 2003, while inflation-adjusted global spending rose ninefold to 2.4 billion US dollars.
Observational
Sí
Global use and spending on ADHD medications increased significantly between 1993 and 2003, driven largely by developed countries adopting more costly formulations.
Little is known about the global use and cost of medications for attention deficit hyperactivity disorder (ADHD). Global use of ADHD medications rose threefold from 1993 through 2003, whereas global spending (2.4 billion US dollars in 2003) rose ninefold, adjusting for inflation. Per capita gross domestic product (GDP) robustly predicted use across countries, but the United States, Canada, and Australia showed significantly higher-than-predicted use. Use and spending grew in both developed and developing countries, but spending growth was concentrated in developed countries, which adopted more costly, long-acting formulations. Promoting optimal prescription and monitoring should be a priority.
Scheffler et al. (Thu,) conducted a observational in Attention deficit hyperactivity disorder (ADHD). ADHD medications was evaluated on Global use and cost of ADHD medications. Global use of ADHD medications rose threefold from 1993 through 2003, while inflation-adjusted global spending rose ninefold to 2.4 billion US dollars.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: